targeted-therapy

Documents about targeted-therapy

• Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma#674900ClinicalTrials.gov
• Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers#917873ClinicalTrials.gov
• Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry#642695Europe PMC
• Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma#919047ClinicalTrials.gov
• Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations#841474ClinicalTrials.gov
• Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy#195315ClinicalTrials.gov
• Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer#829662ClinicalTrials.gov
• Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy#854675ClinicalTrials.gov
• Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy#979205ClinicalTrials.gov
• Prosthesis Infection and One-step Exchange: Pretreatment by Targeted Antibiotic Therapy in At-risk Patients#127633ClinicalTrials.gov
• Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer.#320504NCBI PubMed Central
• Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation.#362158NCBI PubMed Central
• A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients#417555ClinicalTrials.gov
• Therapeutic potential of antisense oligonucleotides in hematological malignancies#468233HAL (France)
• Context-dependent functions of the aryl hydrocarbon receptor in gastrointestinal cancers: from microenvironmental regulation to precision targeted therapy.#653382NCBI PubMed Central
• Research advances in microneedle-exosome delivery systems for the treatment of multisystem diseases#676290Europe PMC
• Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets#676327Europe PMC
• Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.#873840ClinicalTrials.gov
• Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer#883934ClinicalTrials.gov
• Targeted Left Ventricular Lead Placement, Comparison of Active Fixation Bipolar and Passive Quadripolar Pacemaker Leads#884581ClinicalTrials.gov
• Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)#918544ClinicalTrials.gov
• Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer#1007061ClinicalTrials.gov
• Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD#913893ClinicalTrials.gov
• Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis#4614Europe PMC
• Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma#826826ClinicalTrials.gov
• SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC#832936ClinicalTrials.gov
• Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial#161257HAL (France)
• Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy#828112ClinicalTrials.gov
• MMP-Activated Liposomal Nanoplatform Co-loaded with Kaempferol and ICG for Targeted Imaging and Therapy of Abdominal Aortic Aneurysm.#996NCBI PubMed Central
• Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis#181120Southampton
• Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma#474778ClinicalTrials.gov
• Practical management of BRAF inhibitors in glioma: toxicity and resistance#669754Europe PMC
• Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma#804654ClinicalTrials.gov
• Hyaluronic Acid-Modified Celecoxib-Loaded Nanostructured Lipid Carriers Combined with Dissolving Microneedles for Targeted Sustained-Release Therapy in Osteoarthritis.#823593NCBI PubMed Central
• REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients#828474ClinicalTrials.gov
• PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer#831348ClinicalTrials.gov
• Targeted Potassium Levels for Prevention of ICD Therapy#831658ClinicalTrials.gov
• Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC#869527ClinicalTrials.gov
• Encapsulation of NIRF Heptamethine Cyanine Dye with Targeted Metal Organic Carriers: Investigation of Photodynamic Therapy Potential as a Therapeutic Nanoplatform#195206İzmir Yüksek Teknoloji Enstitüsü
• Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma#444870ClinicalTrials.gov
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)#1030691ClinicalTrials.gov
• Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer#801333ClinicalTrials.gov
• A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer#1007928ClinicalTrials.gov
• Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer#123468ClinicalTrials.gov
• Circular RNAs in tumorigenesis: an insight into recent research in biogenesis and targeted tumor therapy#215385Europe PMC
• Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer#238103ClinicalTrials.gov
• Longitudinal Multi-Omic Characterization of Patient Responses to Neoadjuvant HER2-Targeted Therapy#298185api.researchdata.se
• Cardiovascular-kidney-metabolic syndrome through the lens of gut‑derived uremic toxins#307888Europe PMC
• Diacylglycerol kinase eta as a novel target in NRAS mutant melanoma#313265Research Online
• Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma.#427731NCBI PubMed Central